#151 Cardiorenal Considerations: 5 Pearls Segment

#151 Cardiorenal Considerations: 5 Pearls Seg...

Up next

#202 Dementia Part 2: Gray Matters Segment

Most clinicians see dementia medications on the med rec, but many of us aren’t sure how much they actually help. In this episode we break down donepezil, memantine, and the new anti-amyloid drugs, and when to stop them.• Do cholinesterase inhibitors really work?• What should clin ...  Show more

#201: Dementia Part 1: Gray Matters Segment

Cognitive decline is tough for all parties. What are the high-yield questions to ask? What should you add to your one-liner? When do you stop using MOCA and try to clearly describe their functional status? Do all patients with cognitive decline need an MRI?🔹Sponsor: DoxGPT by Do ...  Show more

Recommended Episodes

#326 Cardiorenal Syndrome, Biomarkers, Diuretic Resistance (NephMadness 2022)
The Curbsiders Internal Medicine Podcast

Lose your heart to NephMadness 2022! Dr. Joel Topf (@kidney_boy) and Dr. Sadiya Khan (@HeartDocSadiya) tackle the NephMadness 2022 Cardiorenal Syndrome region, leading us through the pathophysiology of cardiorenal syndrome, how to approach the creatinine “bump” with diuresis, man ...  Show more

REBOOT #145 Hepatorenal Syndrome
The Curbsiders Internal Medicine Podcast

Tackle the complex pathophysiology, diagnosis, and management of hepatorenal syndrome in this Curbsiders classic from #NephMadness 2019 featuring @kidney_boy Joel Topf, HRS expert Juan Carlos Velez (@veleznephhepato), and self-proclaimed most-handsome-nephrologist Bill Whittier ( ...  Show more

#203 - AMA #34: What Causes Heart Disease?
The Peter Attia Drive

<span class="s1"> View the Show Notes Page for This Episode</span>

<span class="s1">

  Show more

Chapter 30: Pharmacology
USMLE Step 2 Secrets

Content covered in this episode includes: [0:29] Question Dissection: A 31-year-old woman is brought to the E.D. by friends at 3 A.M. after they were unable to wake her up... [4:29]Pharmacology chapter of S2S including questions like: - What two developments in NSAID therapy may ...  Show more